Ajanta Pharma, a specialty focused pharmaceutical formulation company, has been listed on Forbes Asia's 'Best Under a Billion' 2014 list. This is the third consecutive listing of the company since 2012.
The ‘Best Under A Billion’ list is published by Forbes Asia to recognize 200 small and midsized publicly listed companies in Asia Pacific region with annual revenue under $1 billion. The companies were selected based on three stringent categories of profitability, growth, and modest indebtedness from a universe of 17,000 stock-traded companies across Asia-Pacific region.
Ajanta Pharma is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: